In addition to blood EXOs, a strong correlation was found between CSF exosomal biomarkers and AD diagnosis since Aβ42, T-tau, and P-T181-tau differed significantly in AD patients and those with MCI and controls [127]. This evidence concerns the gene MAPT and Alzheimer disease.